Skip to main content
. 2021 Nov 22;8:697585. doi: 10.3389/fmed.2021.697585

Table 3.

Blood test parameters in SVI and NSVI patients with and without comorbidities.

Parameter (Mean ± SD) All patients (n = 172) Without comorbidities (n = 87) With comorbidities (n = 85)
SVI NSVI P= SVI NSVI P= SVI NSVI P=
(n = 84) (n = 88) (n = 34) (n = 53) (n = 50) (n = 35)
Accident-blood sample interval (hours) 44.4 ± 76 49.2 ± 92 0.731 57.0 ± 100 39.1 ± 55 0.363 33.1 ± 42 64.8 ± 131 0.171
Hemoglobin (g/dL) 15.0 ± 1.8 15.3 ± 1.2 0.177 15.1 ± 1.8 15.3 ± 1.3 0.408 14.9 ± 1.8 15.2 ± 0.9 0.309
Hematocrit (%) 45.0 ± 5.0 45.9 ± 3.4 0.136 45.1 ± 4.4 46.2 ± 3.8 0.243 44.9 ± 5.5 45.6 ± 2.8 0.485
Leucocytes (K/uL) 11.7 ± 4.0 9.4 ± 3.0 <0.001 11.5 ± 3.6 9.3 ± 2.7 0.001 11.9 ± 4.2 9.6 ± 3.3 0.002
Neutrophils (K/uL) 9.2 ± 4.1 6.7 ± 3.0 <0.001 9.2 ± 3.9 6.7 ± 2.9 0.002 9.2 ± 4.3 6.6 ± 3.1 0.001
Lymphocytes (K/uL) 1.7 ± 0.9 2.1 ± 0.9 0.014 1.5 ± 0.5 1.9 ± 0.8 0.006 1.8 ± 1.0 2.3 ± 0.9 0.011
Platelets (K/uL) 249.0 ± 96 244.7 ± 54 0.709 249.7 ± 61 241.4 ± 48 0.495 249 ± 115 249.8 ± 62 0.954
NLR 7.4 ± 6.6 4.0 ± 3.2 <0.001 7.7 ± 6.6 4.4 ± 3.5 0.001 7.2 ± 6.7 3.5 ± 2.6 <0.001
PLR 167.2 ± 92 139.0 ± 64 0.021 189 ± 100 146.0 ± 63 0.018 152.7 ± 85 128.5 ± 65 0.160
MXD 0.8 ± 0.4 0.8 ± 0.3 0.304 0.7 ± 0.3 0.7 ± 0.3 0.830 0.9 ± 0.4 0.8 ± 0.4 0.508
Glucose (mg/dL) 124.8 ± 50 106.5 ± 35 <0.001 115.1 ± 36 99.0 ± 15 0.070 130.2 ± 56 117.4 ± 51 0.019

SVI, Severe visual impairment; NSVI, Non-SVI; OGI, Open globe injury; SD, Standard deviation; NLR, Neutrophil-to-lymphocyte ratio; PLR, Platelet-to-lymphocyte ratio.

Bold means p < 0.05.